Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 17 April 2027
- Last conf. stmt
- 3 April 2026
Corcept Therapeutics UK Limited
- Incorporated
- 28 March 2017 (9 years)
- Industry
- Manufacture of basic pharmaceutical products (21100) Research and experimental development on biotechnology (72110)
- Directors
- Atabak MokariJoseph Douglas LyonGary Charles Robb
- Accounts type
- Small
- Region
- Greater London
- Address
- Eastcastle House27/28 Eastcastle StreetLondonW1W 8DH
Officers 4 active
Officer details are public data from the Companies House register.
Corporate Secretary · Appointed 12 September 2023
Mokari, Atabak
Director · Appointed 29 July 2021
American
Born September 1976 (50)
Lyon, Joseph Douglas
Director · Appointed 18 August 2020
American
Born October 1977 (49)
Robb, Gary Charles
Director · Appointed 28 March 2017
American
Born December 1962 (63)
Officer history (1 former)
12 September 2023
2 June 2023
29 July 2021
Appointed Mokari, Atabak as Director
18 August 2020
Appointed Lyon, Joseph Douglas as Director
28 March 2017
Appointed Robb, Gary Charles as Director
28 March 2017
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (1)
28 March 2017
Ceased Corcept Therapeutics Incorporated — Owns 75–100% of shares
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Cheshire
Liverpool
Crewe
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →